Spatial Genomics and Transcriptomics Market, 2030
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030, progressing at a CAGR of 23.20%.
The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays and instruments, technological advancements in sequencing technologies, and significant research funding in the field of spatial-based technology for executing R&D exercises.
The market is favored by the development of spatial profiling-based solutions for visualization and analysis of tissue microenvironment, tumor biology, and tissue biomarker. The gradual increase in the prevalence of neurological disorders and rare diseases globally has furthered the spatial genomics and transcripto